{"title":"基于健康筛查结果的日本女性乳腺疾病与代谢综合征因素的关联","authors":"Sakika Sumida, Tadayuki Iida, Masao Yoshikawa, Kaoru Nagaoka","doi":"10.1177/11782234221127652","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The association of obesity with breast cancer is clear. Although body mass index (BMI) is used as an indicator of obesity, its accuracy remains questionable. Although, there factors for diagnosing metabolic syndrome are caused by obesity, the association with breast cancer has not been clarified.</p><p><strong>Methods: </strong>Women who underwent breast cancer screening with mammography and measurements of metabolic syndrome factors, including waist circumference, blood glucose, triglycerides, HDL (high-density lipoprotein) cholesterol levels, and systolic and diastolic pressure, twice within a 2-year period were enrolled (n = 314), with a final sample size of 256. To determine the presence of mammary gland disease, 2 expert physicians interpreted radiogram findings, with category 3 or higher shown by mammography considered to indicate an abnormality.</p><p><strong>Results and conclusions: </strong>Waist circumference at the initial measurement was marginally significant as a risk factor for onset of mammary gland disease (odds ratio [OR] = 1.036, <i>P</i> = .045) and thus was concluded to be a risk factor for disease onset. Although not significant, a 2-year increase in systolic and diastolic blood pressure has been presumed to be risk factors (systolic: OR = 1.020, <i>P</i> = .085, diastolic: OR = 1.040, <i>P</i> = .065), while high levels of HDL cholesterol have been presumed to protect against the disease (OR = 0.982, <i>P</i> = .064). Based on these results, waist circumference and blood pressure are speculated to be related to development of mammary gland disease.</p>","PeriodicalId":9163,"journal":{"name":"Breast Cancer : Basic and Clinical Research","volume":" ","pages":"11782234221127652"},"PeriodicalIF":1.8000,"publicationDate":"2022-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a7/d6/10.1177_11782234221127652.PMC9638686.pdf","citationCount":"0","resultStr":"{\"title\":\"Association of Mammary Gland Disease With Metabolic Syndrome Factors in Japanese Women-Case-Control Study Based on Health Screening Results.\",\"authors\":\"Sakika Sumida, Tadayuki Iida, Masao Yoshikawa, Kaoru Nagaoka\",\"doi\":\"10.1177/11782234221127652\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The association of obesity with breast cancer is clear. Although body mass index (BMI) is used as an indicator of obesity, its accuracy remains questionable. Although, there factors for diagnosing metabolic syndrome are caused by obesity, the association with breast cancer has not been clarified.</p><p><strong>Methods: </strong>Women who underwent breast cancer screening with mammography and measurements of metabolic syndrome factors, including waist circumference, blood glucose, triglycerides, HDL (high-density lipoprotein) cholesterol levels, and systolic and diastolic pressure, twice within a 2-year period were enrolled (n = 314), with a final sample size of 256. To determine the presence of mammary gland disease, 2 expert physicians interpreted radiogram findings, with category 3 or higher shown by mammography considered to indicate an abnormality.</p><p><strong>Results and conclusions: </strong>Waist circumference at the initial measurement was marginally significant as a risk factor for onset of mammary gland disease (odds ratio [OR] = 1.036, <i>P</i> = .045) and thus was concluded to be a risk factor for disease onset. Although not significant, a 2-year increase in systolic and diastolic blood pressure has been presumed to be risk factors (systolic: OR = 1.020, <i>P</i> = .085, diastolic: OR = 1.040, <i>P</i> = .065), while high levels of HDL cholesterol have been presumed to protect against the disease (OR = 0.982, <i>P</i> = .064). Based on these results, waist circumference and blood pressure are speculated to be related to development of mammary gland disease.</p>\",\"PeriodicalId\":9163,\"journal\":{\"name\":\"Breast Cancer : Basic and Clinical Research\",\"volume\":\" \",\"pages\":\"11782234221127652\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2022-11-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a7/d6/10.1177_11782234221127652.PMC9638686.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Breast Cancer : Basic and Clinical Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/11782234221127652\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Breast Cancer : Basic and Clinical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/11782234221127652","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:肥胖与乳腺癌的关系是明确的。虽然身体质量指数(BMI)被用作肥胖的指标,但其准确性仍存在疑问。虽然有诊断代谢综合征的因素是由肥胖引起的,但与乳腺癌的关系尚未明确。方法:在2年内两次接受乳腺癌乳房x线摄影筛查和代谢综合征因素测量的女性(n = 314),包括腰围、血糖、甘油三酯、HDL(高密度脂蛋白)胆固醇水平、收缩压和舒张压。最终样本量为256。为了确定乳腺疾病的存在,2位专家医师解释了x光片的发现,乳房x光片显示的3级或更高级别被认为是异常。结果和结论:初始测量时的腰围作为乳腺疾病发病的危险因素具有边际显著性(优势比[OR] = 1.036, P = 0.045),因此得出腰围是乳腺疾病发病的危险因素。虽然不显著,但2年的收缩压和舒张压升高被认为是危险因素(收缩压:OR = 1.020, P =。085,舒张:OR = 1.040, P = 0.065),而高水平的高密度脂蛋白胆固醇被认为可以预防这种疾病(OR = 0.982, P = 0.064)。基于这些结果,我们推测腰围和血压与乳腺疾病的发展有关。
Association of Mammary Gland Disease With Metabolic Syndrome Factors in Japanese Women-Case-Control Study Based on Health Screening Results.
Background: The association of obesity with breast cancer is clear. Although body mass index (BMI) is used as an indicator of obesity, its accuracy remains questionable. Although, there factors for diagnosing metabolic syndrome are caused by obesity, the association with breast cancer has not been clarified.
Methods: Women who underwent breast cancer screening with mammography and measurements of metabolic syndrome factors, including waist circumference, blood glucose, triglycerides, HDL (high-density lipoprotein) cholesterol levels, and systolic and diastolic pressure, twice within a 2-year period were enrolled (n = 314), with a final sample size of 256. To determine the presence of mammary gland disease, 2 expert physicians interpreted radiogram findings, with category 3 or higher shown by mammography considered to indicate an abnormality.
Results and conclusions: Waist circumference at the initial measurement was marginally significant as a risk factor for onset of mammary gland disease (odds ratio [OR] = 1.036, P = .045) and thus was concluded to be a risk factor for disease onset. Although not significant, a 2-year increase in systolic and diastolic blood pressure has been presumed to be risk factors (systolic: OR = 1.020, P = .085, diastolic: OR = 1.040, P = .065), while high levels of HDL cholesterol have been presumed to protect against the disease (OR = 0.982, P = .064). Based on these results, waist circumference and blood pressure are speculated to be related to development of mammary gland disease.
期刊介绍:
Breast Cancer: Basic and Clinical Research is an international, open access, peer-reviewed, journal which considers manuscripts on all areas of breast cancer research and treatment. We welcome original research, short notes, case studies and review articles related to breast cancer-related research. Specific areas of interest include, but are not limited to, breast cancer sub types, pathobiology, metastasis, genetics and epigenetics, mammary gland biology, breast cancer models, prevention, detection, therapy and clinical interventions, and epidemiology and population genetics.